Chondrocyte-mediated collagenolysis correlates with cartilage destruction grades in osteoarthritis

Clinical and Experimental Rheumatology

Volumn 23, Issue 1, 2005, Pages 19-26

  Konttinen, Yrjö T ^a,b,c   Ma, Jian ^d   Ruuttila, Pasi ^a   Hukkanen, Mika ^b   Santavirta, Seppo ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^c COXA The Joint Replacement Hospital ^*  (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Collagen type II; Collagenase; Osteoarthritis; Pannus

Indexed keywords

COLLAGEN TYPE 2; INTERSTITIAL COLLAGENASE;

AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMUR HEAD; HIP; HUMAN; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN EXPRESSION; SCORING SYSTEM; SYNOVIAL FLUID; TOTAL HIP PROSTHESIS;

AGED; BIOLOGICAL MARKERS; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGEN TYPE II; COLLAGENASES; HUMANS; OSTEOARTHRITIS, HIP; SYNOVIAL FLUID;

EID: 15844425039     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. HEDBOM E, HAUSELMANN HJ: Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002; 59: 45-53.
2. GIBSON GJ, VERNER JJ, NELSON FR, LIN DL: Degradation of the cartilage collagen matrix associated with changes in chondrocytes in osteoarthrosis. Assessment by loss of background fluorescence and immunodetection of matrix components. J Orthop Res 2001; 19: 33-42.
3. EYRE DR, WU JJ, FERNANDES RJ, PIETKA TA, WEIS MA: Recent developments in cartilage research: matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans 2002; 30: 893-9.
4. ROSS MH, ROMRELL LJ, KAYE GI: Histology: A Text and Atlas 3rd ed. A Williams Company, 1995; pg. 137.
5. WU W, BILLINGHURST RC, PIDOUX I et al.: Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 2002; 46: 2087-94.
6. GROSS J, NAGAI Y: Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci USA 1965; 54: 1197-204.
7. KONTTINEN YT, MANDELIN J, LI TF et al.: Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum 2002; 46: 953-60.
8. KAFIENAH W, BROMME D, BUTTLE DJ, CROUCHER LJ, HOLLANDER AP: Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 1998; 331: 727-32.
9. SAKAI T, GROSS J: Some properties of the products of reaction of tadpole collagenase with collagen. Biochemistry 1967; 6: 518-28.
10. WELGUS HG, JEFFREY JJ, EISEN AZ: The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem 1981; 256: 9511-5.
11. GOLDBERG GI, WILHELM SM, KRONBERGER A, BAUER EA, GRANT GA, EISEN AZ: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 1986; 261: 6600-5.
12. COLE AA, CHUBINSKAYA S, SCHUMACHER B et al.: Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996; 271: 11023-6.
13. SUN HB, SMITH GN Jr, HASTY KA, YOKOTA H: Atomic force microscopy-based detection of binding and cleavage site of matrix metalloproteinase on individual type II collagen helices. Anal Biochem 2000; 283: 153-158.
14. MITCHELL PG, MAGNA HA, REEVES LM et al.: Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996; 97: 761-8.
15. LINDY O, KONTTINEN YT, SORSA T et al.: Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997; 40: 1391-9.
16. MAIOTTI M, MONTELEONE G, TARANTINO U, FASCIGLIONE GF, MARINI S, COLETTA M: Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy 2000; 16: 522-526.
17. HUANG W, LI WQ, DEHNADE F, ZAFARULLAH M: Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 2002; 85: 295-303.
18. MARTEL-PELLETIER J, McCOLLUM R, FUJIMOTO N, OBATA K, CLOUTIER JM, PELLETIER JP: Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994; 70: 807-15.
19. CATTERALL JB, CARRERE S, KOSHY PJ et al.: Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 2001; 44: 2296-310.
20. STREMME S, DUERR S, BAU B, SCHMID E, AIGNER T: MMP-8 is only a minor gene product of human adult articular chondrocytes of the knee. Clin Exp Rheumatol 2003; 21: 205-9.
21. NEUHOLD LA, KILLAR L, ZHAO W et al.: Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001; 107: 35-44.
22. HOLLANDER AP, HEATHFIELD TF, WEBBER C et al.: Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994; 93: 1722-32.
23. BILLINGHURST RC, DAHLBERG L, IONESCU M et al.: Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997; 99: 1534-45.
24. ALTMAN R, ALARCON G, APPELROUTH D et al.: The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 505-14.
25. MANKIN HJ, DORFMAN H, LIPPIELLO L, ZARINS A: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971; 53: 523-37.
26. ČEPONIS A, WARIS E, MÖNKKÖNEN J et al.: Effect of low-dose, non-cytotoxic, intraarticular liposomal clodronate on development of erosions and proteoglycan loss in established antigen-induced arthritis in rabbits. Arthritis Rheum 2001; 44: 1908-16.
27. SUKHOVA GK, SCHONBECK U, RABKIN E et al.: Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 99: 2503-9.
28. CHU Q, LOPEZ M, HAYASHI K et al.: Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage 2002; 10: 662-9.
29. HOLLANDER AP, PIDOUX I, REINER A, RORABECK C, BOURNE R, POOLE AR: Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995; 96: 2859-69.
30. AURICH M, POOLE AR, REINER A et al: Matrix homeostasis in aging normal human ankle cartilage. Arthritis Rheum 2002; 46: 2903-10.
31. STOOP R, van der KRAAN PM, BUMA P, HOLLANDER AP, POOLE AR, van den BERG WB: Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage. J Pathol 1999; 188: 329-37.
32. POOLE AR: An introduction to the pathophysiology of osteoarthritis. Front Biosci 1999; 4: D662-70.
33. PRICE JS, CHAMBERS MG, POOLE AR, FRADIN A, MASON RM: Comparison of collagenase-cleaved articular cartilage collagen in mice in the naturally occurring STR/ort model of osteoarthritis and in collagen-induced arthritis. Osteoarthritis Cartilage 2002; 10: 172-9.
34. HANEMAAIJER R, SORSA T, KONTTINEN YT et al.: Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997; 272: 31504-9.
35. KONTTINEN YT, SALO T, HANEMAAIJER R et al.: Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localizationin the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol 1999; 18: 401-12.
36. HODLER J, RESNICK D: Current status of imaging of articular cartilage. Skeletal Radiol 1996; 25: 703-9.
37. CARDONA-CASTRO N, GOTUZZO E, RODRIGUEZ M, GUERRA H: Clinical application of a dot blot test for diagnosis of enteric fever due to Salmonella enterica serovar typhi in patients with typhoid fever from Colombia and Peru. Clin Diagn Lab Immunol 2000; 7: 312-3.
38. MATYAS JR, ATLEY L, IONESCU M, EYRE DR, POOLE AR: Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 2004; 50: 543-52.